Abstract
Mass testing is a promising strategy to control future respiratory virus pandemics, however, it is limited by the availability of testing capacity. The aim of this work is to predict the effectiveness of contact tracing when used with mass testing, and to what extent contact tracing can reduce the required number of tests. We estimate the effect of contact tracing and mass testing for controlling a variety of respiratory virus pandemics. To do this, we use a branching model with individuals whose infectiousness and probability of testing positive depend on simulated viral load trajectories. We find that the addition of contact tracing is most useful when mass testing is done frequently enough to detect most infections, but cannot be done frequently enough to reliably isolate cases before they infect others. Our results show that the addition of effective contact tracing can prevent the same number of transmissions as doubling the mass testing frequency.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All code and data for the present study are available upon reasonable request to the authors
